Spanish group rubbishes rumours of sale

Multiple sources tell HBI Spanish for-profit hospital group Grupo Recoletas is up for sale, and rival HM Hospitales could follow if it hasn't already. Recoletas outright denies there is any process.

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.

Winning the workforce war: Evercare expands training facilities

Many emerging market hospital groups seem a hot ticket at the moment. They have the stability which comes with hospitals, married to far more growth than you might expect in Europe, but the workforce war is making investors think twice. HBI speaks to two experts to learn more about how in-house training is proving to be a solution to workforce woes.

FREE BLOG HBI’s Team Predictions for 2023

Drawing inspiration from prediction lists that make the rounds this time of year like this one from our sources, we asked some of our team here at HBI to pen down some of their thoughts on what we can expect over the next 12 months and beyond. So here are our top picks for news and trends HBI expects will colour 2023 - across hospitals, labs, elderly care, fertility, dentistry, coronavirus, digitisation and more.

Eight predictions for for-profit health care in 2023

2022 was a tumultuous year for for-profit health care. The year began with a sense of things returning to a new normal, after the major disruption of the Covid pandemic throughout 2020 and 2021. But then, not even two months in, Russia invaded Ukraine, and this quickly led to an energy and economic crisis throughout Europe. For the first time in decades inflation reached double-digit figures across almost every OECD country and the era of near-zero interest rates came to an abrupt end. The second half of the year saw major worries about a looming recession and a potential debt crisis, rapidly falling investment and M&A deal volumes slowing to almost a standstill.

How optimistic are US insurers and operators about 2023?

Accounting and Consultancy firm Deloitte US' industry outlook survey of health care operators and investors reveals what 71 c-suite executives of  health systems and insurance with $500m+ revenue think 2023 will hold.

Atrys offloads 25% of Conversia amid stock slump

Spanish based diagnostic labs group Atrys has sold 24.9% of its stake in regulatory compliance subsidiary Conversia to Arragio NW Segundo for €20m. The move comes after a disappointing year where the firm has seen its share price fall 39%.

Softened Hungarian reform still risks workforce exodus

The Hungarian government has removed from its proposed new health care law the requirement that private doctors would need to work at least 20 hours a month in the public sector. However, the rest of the controversial reform remains unaltered.

VC interest in digital health investment remains strong

Despite economic downturn and inflationary pressure, venture capital interest in healthcare, and specifically digital health, remains strong. HBI chats with UK investment company Albion VC to find out more.